l General Information |
Product Name | AGI5198 |
General description | AGI-5198 is the first highly potent and selective inhibitor of IDH1 R132H/R132C mutants. |
Synonym | N-cyclohexyl-2-(3-fluoro-N-[2-(2-methylimidazol-1-yl)acetyl]anilino)-2-(2-methylphenyl)acetamide; AGI-5198; DH-C35; IDHC35; AGI 5198 |
Purity | ≥98%(HPLC) | CAS Number | 1355326-35-0 |
Formula | C27H31FN4O2 | Molecular Weight | 462.569 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White or Off-white solid |
Solubility(25℃) | DMSO | ≥20mg/mL |
Ethanol | ≥10mg/mL |
Water | Insoluble |
l Biological Information |
Biochem/Physiol Actions | AGI-5198 is the first highly potent and selective inhibitor of IDH1 R132H/R132C mutants. |
l Packaging & Storage |
Packaging | 5mg; 25mg |
Storage temp. | -20℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
